X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (196) 196
clinical neurology (140) 140
neurosciences (108) 108
male (100) 100
female (88) 88
middle aged (86) 86
index medicus (82) 82
aged (69) 69
adult (62) 62
neuropathy (55) 55
multifocal motor neuropathy (47) 47
antibodies (45) 45
polyneuropathy (39) 39
neurology (37) 37
immunoglobulins, intravenous - therapeutic use (35) 35
myelin-associated glycoprotein (33) 33
immunoglobulins (32) 32
intravenous immunoglobulin (32) 32
monoclonal gammopathy (31) 31
immunoglobulin m - immunology (28) 28
peripheral nervous system diseases - immunology (28) 28
conduction block (26) 26
double-blind (26) 26
intravenous immunoglobulin treatment (25) 25
aged, 80 and over (23) 23
guillain-barre-syndrome (23) 23
peripheral neuropathy (22) 22
therapy (22) 22
cidp (21) 21
diagnosis (21) 21
enzyme-linked immunosorbent assay (21) 21
chronic inflammatory demyelinating polyradiculoneuropathy (20) 20
immunoglobulin m - blood (20) 20
guillain-barre syndrome (19) 19
myelin-associated glycoprotein - immunology (19) 19
treatment outcome (19) 19
adolescent (18) 18
g ganglioside - immunology (18) 18
ivig (18) 18
settore med/26 - neurologia (18) 18
demyelination (17) 17
gangliosides (17) 17
motor neuron disease - immunology (17) 17
myelin proteins - immunology (17) 17
paraproteinemias - immunology (17) 17
plasma-exchange (17) 17
psychiatry (17) 17
rituximab (17) 17
animals (16) 16
autoantibodies - immunology (15) 15
gangliosides - immunology (15) 15
immunologic factors - therapeutic use (15) 15
medicine & public health (15) 15
polyradiculoneuropathy, chronic inflammatory demyelinating - physiopathology (15) 15
retrospective studies (15) 15
igm (14) 14
immunosuppressive agents - therapeutic use (14) 14
polyradiculoneuropathy, chronic inflammatory demyelinating - drug therapy (14) 14
young adult (14) 14
anti-gm1 antibodies (13) 13
autoantibodies (13) 13
autoantibodies - blood (13) 13
motor neuron disease - physiopathology (13) 13
myelin (13) 13
neuroradiology (13) 13
plasma exchange (13) 13
polyneuropathies - drug therapy (13) 13
polyradiculoneuropathy, chronic inflammatory demyelinating - therapy (13) 13
demyelinating neuropathy (12) 12
disability evaluation (12) 12
guillain-barre syndrome - physiopathology (12) 12
igm monoclonal gammopathy (12) 12
inflammatory demyelinating polyradiculoneuropathy (12) 12
motor neuron disease - drug therapy (12) 12
peripheral nervous system diseases - physiopathology (12) 12
peripheral nervous system diseases - therapy (12) 12
prognosis (12) 12
severity of illness index (12) 12
amyotrophic-lateral-sclerosis (11) 11
care and treatment (11) 11
demyelinating diseases - immunology (11) 11
immunoglobulin m (11) 11
immunology (11) 11
inflammation (11) 11
mag (11) 11
medicine, general & internal (11) 11
nervous system diseases - immunology (11) 11
polyradiculoneuropathy, chronic inflammatory demyelinating - diagnosis (11) 11
surgery (11) 11
time factors (11) 11
criteria (10) 10
follow-up studies (10) 10
guillain-barré syndrome (10) 10
immunoglobulin (10) 10
immunotherapy - methods (10) 10
motor neuron disease - therapy (10) 10
neural conduction (10) 10
polyneuropathies - immunology (10) 10
treatment (10) 10
undetermined significance (10) 10
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
The Lancet Neurology, ISSN 1474-4422, 06/2018, Volume 17, Issue 6, pp. 483 - 485
Journal Article
Cochrane Database of Systematic Reviews, ISSN 1469-493X, 10/2016, Volume 2016, Issue 10, p. CD002827
Background Serum monoclonal anti‐myelin‐associated glycoprotein (anti‐MAG) antibodies may be pathogenic in some people with immunoglobulin M (IgM) paraprotein... 
Immunoglobulin M | Immunosuppressive Agents | Paraproteins | IgM paraproteinaemic demyelinating neuropathy | Rituximab | Myelin‐Associated Glycoprotein | Plasma Exchange | Peripheral neuropathy | Randomized Controlled Trials as Topic | Neurology | Peripheral Nervous System Diseases | Immunotherapy | Paraproteinemias | Medicine General & Introductory Medical Sciences | Demyelinating Diseases | Immunoglobulins, Intravenous | Paraproteinaemic neuropathy | RITUXIMAB TREATMENT | Immunotherapy [methods] | LONG-TERM RESPONSE | WALDENSTROMS MACROGLOBULINEMIA | Humans | Myelin-Associated Glycoprotein [immunology] | INTERMITTENT CYCLOPHOSPHAMIDE | Immunosuppressive Agents [therapeutic use] | Demyelinating Diseases [immunology; therapy] | INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY | Peripheral Nervous System Diseases [immunology; therapy] | Immunoglobulin M [immunology] | MEDICINE, GENERAL & INTERNAL | INTERFERON-ALPHA | Paraproteinemias [immunology; therapy] | INTRAVENOUS IMMUNOGLOBULIN | Immunoglobulins, Intravenous [therapeutic use] | MONOCLONAL GAMMOPATHY | Plasma Exchange [methods] | PLACEBO-CONTROLLED TRIAL | Paraproteins [immunology] | PLASMA-CELL DYSCRASIA | Paraproteinemias - immunology | Immunotherapy - methods | Demyelinating Diseases - therapy | Immunosuppressive Agents - therapeutic use | Paraproteinemias - therapy | Peripheral Nervous System Diseases - therapy | Immunoglobulin M - immunology | Rituximab - therapeutic use | Myelin-Associated Glycoprotein - immunology | Immunoglobulin M - blood | Immunoglobulins, Intravenous - therapeutic use | Plasma Exchange - methods | Demyelinating Diseases - immunology | Peripheral Nervous System Diseases - immunology | Paraproteins - immunology
Journal Article
Journal of the Neurological Sciences, ISSN 0022-510X, 2015, Volume 357, pp. e468 - e469
Journal Article
Journal Article
Lancet Neurology, The, ISSN 1474-4422, 2012, Volume 11, Issue 6, pp. 493 - 502
Journal Article
Neurological Sciences, ISSN 1590-1874, 10/2017, Volume 38, Issue S2, pp. 217 - 224
Journal Article
British Journal of Haematology, ISSN 0007-1048, 12/2017, Volume 179, Issue 5, pp. 748 - 755
Summary Given its anti‐angiogenic activity, lenalidomide may have a role in the treatment of POEMS (Peripheral neuropathy, Organomegaly, Endocrinopathy,... 
dexamethasone | combination therapy | lenalidomide | POEMS syndrome | POLYNEUROPATHY | EFFICACY | SAFETY | THALIDOMIDE | PLUS DEXAMETHASONE | PERIPHERAL NEUROPATHY | OUTCOMES | STEM-CELL TRANSPLANTATION | HEMATOLOGY | SERUM VEGF LEVELS | MYELOMA | Dexamethasone | Angiogenesis inhibitors | Steroids | Angiogenesis | Skin | Peripheral neuropathy | Toxicity | Patients | Index Medicus
Journal Article
European Journal of Neurology, ISSN 1351-5101, 05/2015, Volume 22, Issue 5, pp. 879 - 882
Journal Article